Literature DB >> 33420184

Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils.

Kathryn P Scherpelz1, Songlin Wang2, Peter Pytel1, Rama S Madhurapantula3, Atul K Srivastava1, Joseph R Sachleben4, Joseph Orgel3, Yoshitaka Ishii5, Stephen C Meredith6,7.   

Abstract

Alzheimer's disease is characterized by neuritic plaques, the main protein components of which are β-amyloid (Aβ) peptides deposited as β-sheet-rich amyloid fibrils. Cerebral Amyloid Angiopathy (CAA) consists of cerebrovascular deposits of Aβ peptides; it usually accompanies Alzheimer's disease, though it sometimes occurs in the absence of neuritic plaques, as AD also occurs without accompanying CAA. Although neuritic plaques and vascular deposits have similar protein compositions, one of the characteristic features of amyloids is polymorphism, i.e., the ability of a single pure peptide to adopt multiple conformations in fibrils, depending on fibrillization conditions. For this reason, we asked whether the Aβ fibrils in neuritic plaques differed structurally from those in cerebral blood vessels. To address this question, we used seeding techniques, starting with amyloid-enriched material from either brain parenchyma or cerebral blood vessels (using meninges as the source). These amyloid-enriched preparations were then added to fresh, disaggregated solutions of Aβ to make replicate fibrils, as described elsewhere. Such fibrils were then studied by solid-state NMR, fiber X-ray diffraction, and other biophysical techniques. We observed chemical shift differences between parenchymal vs. vascular-seeded replicate fibrils in select sites (in particular, Ala2, Phe4, Val12, and Gln15 side chains) in two-dimensional 13C-13C correlation solid-state NMR spectra, strongly indicating structural differences at these sites. X-ray diffraction studies also indicated that vascular-seeded fibrils displayed greater order than parenchyma-seeded fibrils in the "side-chain dimension" (~ 10 Å reflection), though the "hydrogen-bond dimensions" (~ 5 Å reflection) were alike. These results indicate that the different nucleation conditions at two sites in the brain, parenchyma and blood vessels, affect the fibril products that get formed at each site, possibly leading to distinct pathophysiological outcomes.

Entities:  

Year:  2021        PMID: 33420184      PMCID: PMC7794565          DOI: 10.1038/s41598-020-80042-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  62 in total

1.  Seeding specificity in amyloid growth induced by heterologous fibrils.

Authors:  Brian O'Nuallain; Angela D Williams; Per Westermark; Ronald Wetzel
Journal:  J Biol Chem       Date:  2004-01-29       Impact factor: 5.157

2.  The growth of cells on a transparent gel of reconstituted rat-tail collagen.

Authors:  R L EHRMANN; G O GEY
Journal:  J Natl Cancer Inst       Date:  1956-06       Impact factor: 13.506

3.  Unraveling structural polymorphism of amyloid fibers.

Authors:  Doryen Bubeck
Journal:  Structure       Date:  2015-01-06       Impact factor: 5.006

Review 4.  β-Amyloid aggregation and heterogeneous nucleation.

Authors:  Atul K Srivastava; Jay M Pittman; Jonathan Zerweck; Bharat S Venkata; Patrick C Moore; Joseph R Sachleben; Stephen C Meredith
Journal:  Protein Sci       Date:  2019-08-06       Impact factor: 6.725

5.  Distinct prion strains are defined by amyloid core structure and chaperone binding site dynamics.

Authors:  Kendra K Frederick; Galia T Debelouchina; Can Kayatekin; Tea Dorminy; Angela C Jacavone; Robert G Griffin; Susan Lindquist
Journal:  Chem Biol       Date:  2014-01-30

Review 6.  ThT 101: a primer on the use of thioflavin T to investigate amyloid formation.

Authors:  Kirsten Gade Malmos; Luis M Blancas-Mejia; Benedikt Weber; Johannes Buchner; Marina Ramirez-Alvarado; Hironobu Naiki; Daniel Otzen
Journal:  Amyloid       Date:  2017-04-10       Impact factor: 7.141

7.  Physical basis for the ofloxacin-induced acceleration of lysozyme aggregation and polymorphism in amyloid fibrils.

Authors:  Shivani A Muthu; Nivin Mothi; Sonali M Shiriskar; Raghuvir R S Pissurlenkar; Anil Kumar; Basir Ahmad
Journal:  Arch Biochem Biophys       Date:  2016-01-08       Impact factor: 4.013

8.  Unlike twins: an NMR comparison of two α-synuclein polymorphs featuring different toxicity.

Authors:  Julia Gath; Luc Bousset; Birgit Habenstein; Ronald Melki; Anja Böckmann; Beat H Meier
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

9.  Species-dependent structural polymorphism of Y145Stop prion protein amyloid revealed by solid-state NMR spectroscopy.

Authors:  Theint Theint; Philippe S Nadaud; Darryl Aucoin; Jonathan J Helmus; Simon P Pondaven; Krystyna Surewicz; Witold K Surewicz; Christopher P Jaroniec
Journal:  Nat Commun       Date:  2017-09-29       Impact factor: 14.919

10.  The structure of a β2-microglobulin fibril suggests a molecular basis for its amyloid polymorphism.

Authors:  Matthew G Iadanza; Robert Silvers; Joshua Boardman; Hugh I Smith; Theodoros K Karamanos; Galia T Debelouchina; Yongchao Su; Robert G Griffin; Neil A Ranson; Sheena E Radford
Journal:  Nat Commun       Date:  2018-10-30       Impact factor: 14.919

View more
  3 in total

Review 1.  The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics.

Authors:  Eric Karran; Bart De Strooper
Journal:  Nat Rev Drug Discov       Date:  2022-02-17       Impact factor: 112.288

2.  In-Cell Sensitivity-Enhanced NMR of Intact Viable Mammalian Cells.

Authors:  Rupam Ghosh; Yiling Xiao; Jaka Kragelj; Kendra K Frederick
Journal:  J Am Chem Soc       Date:  2021-11-01       Impact factor: 15.419

3.  Mechanism of Zhinao Capsule in Treating Alzheimer's Disease Based on Network Pharmacology Analysis and Molecular Docking Validation.

Authors:  Yanzhen Ma; Shaopeng Huang; Hui Jiang; Wenming Yang
Journal:  J Healthc Eng       Date:  2022-08-18       Impact factor: 3.822

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.